Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: Identification of sirtuin 1 as a regulator of the KSHV life cycle

Journal of Virology

Volumn 88, Issue 11, 2014, Pages 6355-6367

  Li, Qiuhua ^a   He, Meilan ^b   Zhou, Fuchun ^a,c   Ye, Fengchun ^a   Gao, Shou Jiang ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HISTONE H4; NICOTINAMIDE; SIRTINOL; SIRTUIN 1;

ARTICLE; CONTROLLED STUDY; ENZYME BINDING; GENE SILENCING; HISTONE ACETYLATION; HUMAN HERPESVIRUS 8; INTERLEUKIN 6 GENE; LIFE CYCLE; NONHUMAN; ORF57 GENE; ORF59 GENE; ORF65 GENE; PRIORITY JOURNAL; PROMOTER REGION; SIRT1 GENE; VIRION; VIRUS ACTIVATION; VIRUS GENE; VIRUS LATENCY; VIRUS REPLICATION;

BENZAMIDES; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; GENE EXPRESSION REGULATION, VIRAL; GENE KNOCKDOWN TECHNIQUES; HERPESVIRUS 8, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOPRECIPITATION; LUCIFERASES; MICROSCOPY, CONFOCAL; NAPHTHOLS; NIACINAMIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIRTUIN 1; TRANS-ACTIVATORS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84899820794     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00219-14     Document Type: Article

References (59)

1. Ye FC, Lei XF, Gao SJ. 2011. Mechanisms of Kaposi's sarcoma-associated herpesvirus latency and reactivation. Adv. Virol. 2011:193860. http://dx. doi. org/10. 1155/2011/193860.
2. Lukac DM, Renne R, Kirshner JR, Ganem D. 1998. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252:304-312. http://dx. doi. org/10. 1006/viro. 1998. 9486.
3. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G. 1998. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA. 95:10866-10871. http://dx. doi. org/10. 1073/pnas. 95. 18. 10866.
4. Cattelan AM, Calabro ML, Gasperini P, Aversa SM, Zanchetta M, Meneghetti F, De Rossi A, Chieco-Bianchi L. 2001. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. J. Natl. Cancer Inst. Monogr. 28:44-49. http://jncimono. oxfordjournals. org/content/2000/28/44. long.
5. Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamache CJ, Whitby D, Goedert JJ. 2003. Detection and quantification of Kaposi's sarcomaassociated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS 17:1847-1851. http://dx. doi. org/10. 1097/00002030-200308150-00015.
6. Guadalupe M, Pollock BH, Westbrook S, Redding S, Bullock D, Anstead G, Agan BK, Marconi VC, Barbieri S, Sankar V, Rebeles J, Flahive Y, Schoolfield J, Wang L, Lei X, Dow D, Yeh CK, Dang H, Infante AJ, Gao SJ. 2011. Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 56:83-90. http://dx. doi. org/10. 1097/QAI. 0b013e3181fdc928.
7. Alkhatib SG, Landry JW. 2011. The nucleosome remodeling factor. FEBS Lett. 585:3197-3207. http://dx. doi. org/10. 1016/j. febslet. 2011. 09. 003.
8. Michan S, Sinclair D. 2007. Sirtuins in mammals: insights into their biological function. Biochem. J. 404:1-13. http://dx. doi. org/10. 1042/BJ20070140.
9. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D. 2004. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol. Cell 16:93-105. http://dx. doi. org/10. 1016/j. molcel. 2004. 08. 031.
10. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W. 2001. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107:137-148. http://dx. doi. org/10. 1016/S0092-8674(01)00524-4.
11. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA. 2001. hSIR2(SIRT1) functions as an NADdependent p53 deacetylase. Cell 107:149-159. http://dx. doi. org/10. 1016/S0092-8674(01)00527-X.
12. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME. 2004. Stressdependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011-2015. http://dx. doi. org/10. 1126/science. 1094637.
13. Lu F, Zhou J, Wiedmer A, Madden K, Yuan Y, Lieberman PM. 2003. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J. Virol. 77: 11425-11435. http://dx. doi. org/10. 1128/JVI. 77. 21. 11425-11435. 2003.
14. Miller G, Rigsby MO, Heston L, Grogan E, Sun R, Metroka C, Levy JA, Gao SJ, Chang Y, Moore P. 1996. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N. Engl. J. Med. 334:1292-1297. http://dx. doi. org/10. 1056/NEJM199605163342003.
15. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:342-346. http://dx. doi. org/10. 1038/nm0396-342.
16. Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, Hettler E, Gao SJ. 2002. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J. Virol. 76:6185-6196. http://dx. doi. org/10. 1128/JVI. 76. 12. 6185-6196. 2002.
17. Chen J, Ye F, Xie J, Kuhne K, Gao SJ. 2009. Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA. Virology 386:290-302. http://dx. doi. org/10. 1016/j. virol. 2009. 01. 031.
18. Deng H, Young A, Sun R. 2000. Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. J. Gen. Virol. 81: 3043-3048. http://vir. sgmjournals. org/content/81/12/3043. long.
19. Deng H, Song MJ, Chu JT, Sun R. 2002. Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol. 76:8252-8264. http://dx. doi. org/10. 1128/JVI. 76. 16. 8252-8264. 2002.
20. He M, Zhang W, Bakken T, Schutten M, Toth Z, Jung JU, Gill P, Cannon M, Gao SJ. 2012. Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2. Cancer Res. 72:3582-3592. http://dx. doi. org/10. 1158/0008-5472. CAN-11-2876.
21. Moody R, Zhu Y, Huang Y, Cui X, Jones T, Bedolla R, Lei X, Bai Z, Gao SJ. 2013. KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. PLoS Pathog. 9:e1003857. http://dx. doi. org/10. 1371/journal. ppat. 1003857.
22. Li Q, Zhou F, Ye F, Gao SJ. 2008. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Virology 379:234-244. http://dx. doi. org/10. 1016/j. virol. 2008. 06. 043.
23. Ye FC, Zhou FC, Xie JP, Kang T, Greene W, Kuhne K, Lei XF, Li QH, Gao SJ. 2008. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency. J. Virol. 82:4235-4249. http://dx. doi. org/10. 1128/JVI. 02370-07.
24. Greene W, Zhang W, He M, Witt C, Ye F, Gao SJ. 2012. The ubiquitin/proteasome system mediates entry and endosomal trafficking of Kaposi's sarcoma-associated herpesvirus in endothelial cells. PLoS Pathog. 8:e1002703. http://dx. doi. org/10. 1371/journal. ppat. 1002703.
25. Gao SJ, Deng JH, Zhou FC. 2003. Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells. J. Virol. 77:9738-9749. http://dx. doi. org/10. 1128/JVI. 77. 18. 9738-9749. 2003.
26. Jones T, Ye FC, Bedolla RG, Meng FHYJ, Qian LW, Pan HY, Zhou FC, Moody R, Wagner B, Arar M, Gao SJ. 2012. Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV. J. Clin. Invest. 122:1076-1081. http://dx. doi. org/10. 1172/JCI58530.
27. Ye FC, Blackbourn DJ, Mengel M, Xie JP, Qian LW, Greene W, Yeh IT, Graham D, Gao SJ. 2007. Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1. J. Virol. 81:3980-3991. http://dx. doi. org/10. 1128/JVI. 02089-06.
28. Deng JH, Zhang YJ, Wang XP, Gao SJ. 2004. Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation. J. Virol. 78:11108-11120. http://dx. doi. org/10. 1128/JVI. 78. 20. 11108-11120. 2004.
29. Xie J, Ajibade AO, Ye F, Kuhne K, Gao SJ. 2008. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Virology 371:139-154. http://dx. doi. org/10. 1016/j. virol. 2007. 09. 040.
30. Ye F, Zhou F, Bedolla RG, Jones T, Lei X, Kang T, Guadalupe M, Gao SJ. 2011. Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog. 7:e1002054. http://dx. doi. org/10. 1371/journal. ppat. 1002054.
31. Vaquero A, Scher M, Erdjument-Bromage H, Tempst P, Serrano L, Reinberg D. 2007. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature 450:440-444. http://dx. doi. org/10. 1038/nature06268.
32. Patel DJ, Wang Z. 2013. Readout of epigenetic modifications. Annu. Rev. Biochem. 82:81-118. http://dx. doi. org/10. 1146/annurev-biochem-072711-165700.
33. Lukac DM, Kirshner JR, Ganem D. 1999. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73:9348-9361.
34. Yu Y, Wang SE, Hayward GS. 2005. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22:59-70. http://dx. doi. org/10. 1016/j. immuni. 2004. 11. 011.
35. Toth Z, Maglinte DT, Lee SH, Lee HR, Wong LY, Brulois KF, Lee S, Buckley JD, Laird PW, Marquez VE, Jung JU. 2010. Epigenetic analysis ofKSHVlatent and lytic genomes. PLoS Pathog. 6:e1001013. http://dx. doi. org/10. 1371/journal. ppat. 1001013.
36. Gunther T, Grundhoff A. 2010. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 6:e1000935. http://dx. doi. org/10. 1371/journal. ppat. 1000935.
37. Krithivas A, Young DB, Liao G, Greene D, Hayward SD. 2000. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J. Virol. 74:9637-9645. http://dx. doi. org/10. 1128/JVI. 74. 20. 9637-9645. 2000.
38. Krithivas A, Fujimuro M, Weidner M, Young DB, Hayward SD. 2002. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J. Virol. 76:11596-11604. http://dx. doi. org/10. 1128/JVI. 76. 22. 11596-11604. 2002.
39. Shamay M, Krithivas A, Zhang J, Hayward SD. 2006. Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc. Natl. Acad. Sci. USA. 103:14554-14559. http://dx. doi. org/10. 1073/pnas. 0604469103.
40. Lei X, Bai Z, Ye F, Xie J, Kim CG, Huang Y, Gao SJ. 2010. Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat. Cell Biol. 12:193-199. http://dx. doi. org/10. 1038/ncb 2019.
41. Chang J, Renne R, Dittmer D, Ganem D. 2000. Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology 266:17-25. http://dx. doi. org/10. 1006/viro. 1999. 0077.
42. Haque M, Davis DA, Wang V, Widmer I, Yarchoan R. 2003. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia. J. Virol. 77: 6761-6768. http://dx. doi. org/10. 1128/JVI. 77. 12. 6761-6768. 2003.
43. Gregory SM, West JA, Dillon PJ, Hilscher C, Dittmer DP, Damania B. 2009. Toll-like receptor signaling controls reactivation of KSHV from latency. Proc. Natl. Acad. Sci. USA. 106:11725-11730. http://dx. doi. org/10. 1073/pnas. 0905316106.
44. Qin D, Feng N, Fan W, Ma X, Yan Q, Lv Z, Zeng Y, Zhu J, Lu C. 2011. Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1. BMC Microbiol. 11:240. http://dx. doi. org/10. 1186/1471-2180-11-240.
45. Zhu X, Zhou F, Qin D, Zeng Y, Lv Z, Yao S, Lu C. 2011. Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi'ssarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-kappaB signaling pathways. J. Mol. Biol. 410:1035-1051. http://dx. doi. org/10. 1016/j. jmb. 2011. 03. 055.
46. Lu C, Zeng Y, Huang Z, Huang L, Qian C, Tang G, Qin D. 2005. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcomaassociated herpesvirus. Am. J. Pathol. 166:173-183. http://dx. doi. org/10. 1016/S0002-9440(10)62242-0.
47. Haigis MC, Sinclair DA. 2010. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5:253-295. http://dx. doi. org/10. 1146/annurev. pathol. 4. 110807. 092250.
48. +. Cell 129:473-484. http://dx. doi. org/10. 1016/j. cell. 2007. 03. 024.
49. Stedman W, Kang H, Lin S, Kissil JL, Bartolomei MS, Lieberman PM. 2008. Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. EMBO J. 27:654-666. http://dx. doi. org/10. 1038/emboj. 2008. 1.
50. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D. 2002. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev. 16:1977-1989. http://dx. doi. org/10. 1101/gad. 996502.
51. Sakakibara S, Ueda K, Chen J, Okuno T, Yamanishi K. 2001. Octamerbinding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression. J. Virol. 75: 6894-6900. http://dx. doi. org/10. 1128/JVI. 75. 15. 6894-6900. 2001.
52. Gwack Y, Byun H, Hwang S, Lim C, Choe J. 2001. CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50. J. Virol. 75:1909-1917. http://dx. doi. org/10. 1128/JVI. 75. 4. 1909-1917. 2001.
53. Gwack Y, Nakamura H, Lee SH, Souvlis J, Yustein JT, Gygi S, Kung HJ, Jung JU. 2003. Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication. Mol. Cell. Biol. 23:8282-8294. http://dx. doi. org/10. 1128/MCB. 23. 22. 8282-8294. 2003.
54. Izumiya Y, Lin SF, Ellison T, Chen LY, Izumiya C, Luciw P, Kung HJ. 2003. Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. J. Virol. 77:1441-1451. http://dx. doi. org/10. 1128/JVI. 77. 2. 1441-1451. 2003.
55. Lan K, Kuppers DA, Verma SC, Robertson ES. 2004. Kaposi's sarcomaassociated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virusmediated control of latency. J. Virol. 78:6585-6594. http://dx. doi. org/10. 1128/JVI. 78. 12. 6585-6594. 2004.
56. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, Garcia JA. 2009. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 324:1289-1293. http://dx. doi. org/10. 1126/science. 1169956.
57. Amat R, Planavila A, Chen SL, Iglesias R, Giralt M, Villarroya F. 2009. SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD. J. Biol. Chem. 284:21872-21880. http://dx. doi. org/10. 1074/jbc. M109. 022749.
58. Dey S, Bakthavatchalu V, Tseng MT, Wu P, Florence RL, Grulke EA, Yokel RA, Dhar SK, Yang HS, Chen Y, St Clair DK. 2008. Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells. Carcinogenesis 29:1920-1929. http://dx. doi. org/10. 1093/carcin/bgn175.
59. Das C, Lucia MS, Hansen KC, Tyler JK. 2009. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459:113-117. http://dx. doi. org/10. 1038/nature07861.